PharmaCielo Ltd. PCLOF OTC

PharmaCielo Ltd. (PCLOF) generated $530.31K in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $4.00, free cash flow was $530.32K.

Free cash flow margin was 87.6% of revenue. Cash conversion ratio was 1.3x, indicating earnings are backed by cash.

Criteria supported by this page:

• HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (29/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (10/100) — Cash conversion ratio was 1.3x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 23/100 with 1/7 criteria passed.